ATP-sensitive potassium channels regulate in vivo dopamine release in rat striatum

Japanese Journal of Pharmacology

Volumn 79, Issue 1, 1999, Pages 59-64

  Zhu, Dawn Xiao Dong ^a   Sullivan, James P ^a   Brioni, Jorge D ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Amphetamine; Cromakalim; Dopamine; Glyburide; Microdialysis

Indexed keywords

ADENOSINE TRIPHOSPHATE; CROMAKALIM; DEXAMPHETAMINE; DIAZOXIDE; DOPAMINE; GLIBENCLAMIDE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOSE TIME EFFECT RELATION; MALE; MICRODIALYSIS; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032968459     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.79.59     Document Type: Article

References (25)

1. Ashcroft FM: Adenosine 5′'-triphosphate-sensitive potassium channels. Annu Rev Neurosci 11, 97-118 (1988)
2. 125I]iodoglyburide, a novel high-affinity ligand for ATP-sensitive potassium channels in rat brain. J Pharmacol Exp Ther 257, 901-907 (1991)
3. + channels in cardiac muscle. Nature 305, 147-148 (1983)
4. + channel openers block sulpiride-induced dopamine release in the rat striatum. Eur J Pharmacol 297, 35-41 (1996)
5. + channels. Science 247, 852-854 (1990)
6. Edwards G and Weston AH: Pharmacology of the potassium channel openers. Cardiovasc Drugs Ther 9, 185-193 (1996)
7. ATP channels of mammalian skeletal muscle. J Membr Biol 155, 257-262 (1997)
8. + channels and block neurosecretion. Proc Natl Acad Sci USA 87, 3489-3492 (1990)
9. Edwards G and Weston AH: Recent advances in the pharmacology and therapeutic potential of potassium channel openers. Exp Opin Invest Drugs 5, 1453-1464 (1996b)
10. Empfield JR, Russell K and Trainer A: Potassium channel openers: therapeutic possibilities. Pharmacol News 2, 23-27 (1995)
11. Albin RL, Young AB and Penney JB: The functional anatomy of basal ganglia disorders. Trends Neurosci 12, 366-375 (1989)
12. Mourre C, Ben-Ari Y, Bernardi H, Fosset M and Lazdunski M: Antidiabetic sulfonylurea: localization of binding sites in the brain and effects on the hyperpolarization induced by anoxia in hippocampal slices. Brain Res 486, 159-164 (1989)
13. 3H]glibenclamide binding sites in rat neuronal and cardiac tissue: localization and developmental characteristics. J Pharmacol Exp Ther 256, 358-364 (1991)
14. Westerink BHC, Damsma H, Rollema H, De Vries JB and Horn AS: Scope and limitations of in vivo brain dialysis: A comparison of its application to various neurotransmitter systems. Life Sci 41, 1763-1776 (1987)
15. Zhu XD and Giacobini E: Second generation cholinesterase inhibitor: Effect of (L)-Huperzine-A on cortical biogenic amines. J Neurosci Res 41, 828-835 (1995)
16. Paxinos G and Watson C: The Rat Brain in Stereotaxic Coordinates, 2nd Edition, Academic Press, Harcourt Brace Jovanovich, Publishers, New York (1986)
17. Cook N: The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci 9, 21-28 (1988)
18. + channel. J Biol Chem 271, 24321-24324 (1996)
19. ATP channel-forming Kir 6.2 subunit and the sulfonylurea receptor SUR1 in rodent brain. FEBS Lett 401, 59-64 (1997)
20. Treherne JM and Ashford ML: The regional distribution of sulfonylurea binding sites in rat brain. Neuroscience 40, 523-531 (1991)
21. During MJ, Leone P, Davis KE, Kerr D and Sherwin RS: Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest 95, 2403-2408 (1995)
22. Nicoll R: The coupling of neurotransmitter receptors to ion channels in the brain. Science 241, 545-550 (1988)
23. Aguilar-Bryan L, Nichols C, Wechler S, Clement J, Boyd A, Gonzalez G, Herrera-Sosa H, Nguy K, Bryan J and Nelson D: Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268, 423-426 (1995)
24. + channel in insulin-secreting cells. J Biochem 33, 15840-15844 (1987)
25. Fink SJ and Smith GP: Relationships between selective enervation of dopamine terminal fields in the anterior forebrain and behavioral response to amphetamine and apomorphine. Brain Res 201, 107-127 (1980)